Suppr超能文献

目前用于 COVID-19 感染诊断的创新方法(综述)。

Current and innovative methods for the diagnosis of COVID‑19 infection (Review).

机构信息

Epidemiology and Biostatistics Unit, National Cancer Institute‑IRCCS 'Fondazione G. Pascale', I‑80131 Naples, Italy.

Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95123 Catania, Italy.

出版信息

Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4933. Epub 2021 Apr 13.

Abstract

The Coronavirus Disease 2019 (COVID‑19) pandemic has forced the scientific community to rapidly develop highly reliable diagnostic methods in order to effectively and accurately diagnose this pathology, thus limiting the spread of infection. Although the structural and molecular characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) were initially unknown, various diagnostic strategies useful for making a correct diagnosis of COVID‑19 have been rapidly developed by private research laboratories and biomedical companies. At present, rapid antigen or antibody tests, immunoenzymatic serological tests and molecular tests based on RT‑PCR are the most widely used and validated techniques worldwide. Apart from these conventional methods, other techniques, including isothermal nucleic acid amplification techniques, clusters of regularly interspaced short palindromic repeats/Cas (CRISPR/Cas)‑based approaches or digital PCR methods are currently used in research contexts or are awaiting approval for diagnostic use by competent authorities. In order to provide guidance for the correct use of COVID‑19 diagnostic tests, the present review describes the diagnostic strategies available which may be used for the diagnosis of COVID‑19 infection in both clinical and research settings. In particular, the technical and instrumental characteristics of the diagnostic methods used are described herein. In addition, updated and detailed information about the type of sample, the modality and the timing of use of specific tests are also discussed.

摘要

2019 年冠状病毒病(COVID-19)大流行迫使科学界迅速开发高度可靠的诊断方法,以便能够有效和准确地诊断这种疾病,从而限制感染的传播。尽管严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的结构和分子特征最初并不为人所知,但私人研究实验室和生物医学公司迅速开发了各种有助于正确诊断 COVID-19 的诊断策略。目前,快速抗原或抗体检测、免疫酶联血清学检测和基于 RT-PCR 的分子检测是全球应用最广泛和最有效的技术。除了这些常规方法外,其他技术,包括等温核酸扩增技术、规律成簇间隔短回文重复序列/ Cas(CRISPR/Cas)方法或数字 PCR 方法,目前正在研究中使用或正在等待主管当局批准用于诊断用途。为了为 COVID-19 诊断测试的正确使用提供指导,本综述描述了现有的诊断策略,这些策略可用于临床和研究环境中 COVID-19 感染的诊断。特别是,本文描述了所使用诊断方法的技术和仪器特性。此外,还讨论了关于特定检测的样本类型、方式和使用时间的最新和详细信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8043662/dd6f97f99c44/IJMM-47-06-04933-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验